Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

UPDATE 1-Australia considers diverting COVID-19 vaccines to PNG as "disaster" looms

Published 26/03/2021, 06:48 pm
Updated 26/03/2021, 06:54 pm

(Updates with latest case numbers, paragraph 11)

By Colin Packham

CANBERRA, March 26 (Reuters) - Australia is considering diverting COVID-19 inoculations from its vaccination programme to Papua New Guinea (PNG) where the coronavirus is threatening to unleash a humanitarian disaster, a government source said on Friday.

PNG is due to get 588,000 doses of vaccine by June under the COVAX initiative to help poorer countries but doubts have arisen about those supplies given new restrictions imposed in producing countries as the virus spreads.

The European Union is implementing tougher vaccine export controls and has yet to respond to an Australian request that it release 1 million doses of AstraZeneca (NASDAQ:AZN)'s AZN.L vaccine that has been contracted to go to Australia, to PNG instead, the source told Reuters. has put a temporary hold on all major exports of the AstraZeneca shot made by the Serum Institute of India to meet domestic demand, which will almost certainly delay deliveries to PNG. is growing concern that PNG, an island nation of about 10 million people, many living in impoverished, isolated communities, can't afford to wait.

"We have a humanitarian disaster unfolding in our backyard," said the source, who is familiar with the thinking of the government on the issue. The source declined to be identified as he is not authorised to talk to the media.

Australia is still lobbying the EU for the 1 million doses but considering other options, the source said.

"No decision has yet been made but the government is considering sending vaccines," said the source, who did not comment on any quantity of doses being discussed.

A government spokesman declined to comment.

'TOO URGENT'

PNG, which was administered by Australia before its independence, has recorded more than 4,600 cases of the virus and 39 deaths, according to figures released on Thursday.

But Australia says those tallies vastly understate the extent of the crisis as the Pacific country does not do mass testing.

PNG's biggest hospitals have reported that as many as 80% are coming back positive and Prime Minister James Marape has said the virus has "broken loose".

The only vaccines PNG has received are just over 8,000 doses that Australia sent for health workers. Australian government is absolutely right to be pressing the EU on this matter but the situation is too urgent to wait," said Marc Purcell, CEO of the Australian Council for International Development, which represents aid agencies.

The Australian government now faces the politically sensitive question of whether to send PNG doses of the AstraZeneca vaccine at the early stages of its own vaccine campaign.

Biotech company CSL CSL.AX is due to supply Australia with 50 million doses of the AstraZeneca vaccine that it has begun producing in Australia to help inoculate the entire population of about 26 million by the end of the year.

Australia has largely managed to get to grips with the coronavirus through lockdowns, distancing, contact tracing and border controls. It has reported just over 29,200 cases and 909 deaths.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.